Checks heart inflammation after first smallpox vaccination
Part of Infections clinical trials.
This study looks at whether people develop myocarditis (inflammation of the heart muscle) after getting a first-time, non-replicating smallpox vaccine. It may help doctors understand who is at risk and how to monitor after vaccination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are active duty military and between ages 18 and 45
- You are getting smallpox vaccine for the first time (not previously vaccinated)
- A routine immunization screening already says you are eligible for this vaccine
- You do not have a known reason you cannot receive JYNNEOS™ (per the official vaccine instructions)
- You can attend required follow-up visits (no deployment/PCS/TDY planned for 65 days after the first visit)
- You can understand and sign informed consent (and you are not currently moderately or severely ill)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.
This trial tests an MVA-based vaccine (MVA-SIBP) to see if it is safe and creates a good immune response against smallpox and mpox. It's for healthy people in certain age groups who have not had these vaccines or infections before.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
This early-phase trial tests a single or multiple doses of BSY001 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 50 who are not allergic to similar drugs and can avoid certain medicines and activities during the study.
This is a first-in-human safety study testing a new experimental immune therapy called JST-018. Researchers want to see how safe it is, how well your body tolerates it, and how your body processes it when given as an injection.
This study looks at how well the mpox vaccine works during outbreaks. It tracks people who may have been exposed, those who have been vaccinated or already had mpox, and healthy volunteers.
Hear when a new Myopericarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.